FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4362596503> ?p ?o ?g. }

• W4362596503 endingPage "2784" @default.
• W4362596503 startingPage "2784" @default.
• W4362596503 abstract "Abstract Melanoma is the most lethal skin cancer, with the increasing incidence in the past decade. Despite the significant advancements in immune therapy and targeted therapy, the overall prognosis for metastatic melanoma remains unsatisfactory. TP53 is a tumor suppressor, but its wildtype is inactivated in about 90% of melanoma. Since activated p53 can promote cancer cell apoptosis and thus effectively inhibit tumor growth and tumor metastasis, reactivation of p53 is considered a promising strategy for cancer therapy. Herein, we report a recently developed small molecule compound, JW-1-283, targeting the interactions between MDM2 E3 ubiquitin-protein ligase and p53 protein. In vitro, JW-1-283 showed potent cytotoxicity against A375 melanoma cell line (IC50 2.2±0.3 μM) which has wildtype p53, but its potency is substantially reduced in two other melanoma cell lines with either p53 mutation (M14) or p53 null (RPMI-7951) status. Treatment with JW-1-283 significantly dose-dependently reduced the stemness in A375 melanoma cells, as indicated by low numbers of colony formation, impaired tumor sphere formation abilities, and inhibition of cancer cell migration. Mechanistically, JW-1-283 disrupts the p53-MDM2 interaction, prevents p53 and MDM2 degradation in the existence of cycloheximide, and induces p38 and p53 phosphorylation in the apoptotic pathway. Genetic knockdown of p38 by siRNA further confirmed that the stabilized p53 could be subsequently phosphorylated by p38, leading to induced apoptosis as well as S phase cell cycle arrest. In vivo, when A375 tumors grown in NSG mice were treated with 7.5 mg/kg of JW-1-283 intraperitoneally every other day for a consecutive of 16 days, significant inhibition of tumor growth was observed, along with decreased tumor cell proliferation, tumor angiogenesis, and enhanced tumor cell apoptosis. In summary, this work provides the initial proof-of-concept of developing the JW-1-283 scaffold as a potential strategy for advanced melanoma, which inhibits tumor growth by activating the p53 signaling pathway. Citation Format: Yang Xie, Kelli Hartman, Zhongzhi Wu, Wei Li. JW-1-283 inhibits melanoma tumor growth via the stabilization of p53 pathway [abstract]. In: Proceedings of the American Association for Cancer Research Annual Meeting 2023; Part 1 (Regular and Invited Abstracts); 2023 Apr 14-19; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2023;83(7_Suppl):Abstract nr 2784." @default.
• W4362596503 created "2023-04-06" @default.
• W4362596503 creator A5000432967 @default.
• W4362596503 creator A5030693092 @default.
• W4362596503 creator A5041926241 @default.
• W4362596503 creator A5059616654 @default.
• W4362596503 date "2023-04-04" @default.
• W4362596503 modified "2023-10-16" @default.
• W4362596503 title "Abstract 2784: JW-1-283 inhibits melanoma tumor growth via the stabilization of p53 pathway" @default.
• W4362596503 doi "https://doi.org/10.1158/1538-7445.am2023-2784" @default.
• W4362596503 hasPublicationYear "2023" @default.
• W4362596503 type Work @default.
• W4362596503 citedByCount "0" @default.
• W4362596503 crossrefType "journal-article" @default.
• W4362596503 hasAuthorship W4362596503A5000432967 @default.
• W4362596503 hasAuthorship W4362596503A5030693092 @default.
• W4362596503 hasAuthorship W4362596503A5041926241 @default.
• W4362596503 hasAuthorship W4362596503A5059616654 @default.
• W4362596503 hasConcept C104317684 @default.
• W4362596503 hasConcept C105696609 @default.
• W4362596503 hasConcept C121608353 @default.
• W4362596503 hasConcept C126322002 @default.
• W4362596503 hasConcept C134459356 @default.
• W4362596503 hasConcept C190283241 @default.
• W4362596503 hasConcept C25602115 @default.
• W4362596503 hasConcept C2776192174 @default.
• W4362596503 hasConcept C2777221213 @default.
• W4362596503 hasConcept C2777658100 @default.
• W4362596503 hasConcept C29537977 @default.
• W4362596503 hasConcept C502942594 @default.
• W4362596503 hasConcept C55493867 @default.
• W4362596503 hasConcept C62112901 @default.
• W4362596503 hasConcept C71924100 @default.
• W4362596503 hasConcept C86803240 @default.
• W4362596503 hasConceptScore W4362596503C104317684 @default.
• W4362596503 hasConceptScore W4362596503C105696609 @default.
• W4362596503 hasConceptScore W4362596503C121608353 @default.
• W4362596503 hasConceptScore W4362596503C126322002 @default.
• W4362596503 hasConceptScore W4362596503C134459356 @default.
• W4362596503 hasConceptScore W4362596503C190283241 @default.
• W4362596503 hasConceptScore W4362596503C25602115 @default.
• W4362596503 hasConceptScore W4362596503C2776192174 @default.
• W4362596503 hasConceptScore W4362596503C2777221213 @default.
• W4362596503 hasConceptScore W4362596503C2777658100 @default.
• W4362596503 hasConceptScore W4362596503C29537977 @default.
• W4362596503 hasConceptScore W4362596503C502942594 @default.
• W4362596503 hasConceptScore W4362596503C55493867 @default.
• W4362596503 hasConceptScore W4362596503C62112901 @default.
• W4362596503 hasConceptScore W4362596503C71924100 @default.
• W4362596503 hasConceptScore W4362596503C86803240 @default.
• W4362596503 hasIssue "7_Supplement" @default.
• W4362596503 hasLocation W43625965031 @default.
• W4362596503 hasOpenAccess W4362596503 @default.
• W4362596503 hasPrimaryLocation W43625965031 @default.
• W4362596503 hasRelatedWork W2016433185 @default.
• W4362596503 hasRelatedWork W2319526902 @default.
• W4362596503 hasRelatedWork W2350294409 @default.
• W4362596503 hasRelatedWork W2358789216 @default.
• W4362596503 hasRelatedWork W2379033026 @default.
• W4362596503 hasRelatedWork W2605273235 @default.
• W4362596503 hasRelatedWork W2770351100 @default.
• W4362596503 hasRelatedWork W2885201285 @default.
• W4362596503 hasRelatedWork W3162856593 @default.
• W4362596503 hasRelatedWork W4361825194 @default.
• W4362596503 hasVolume "83" @default.
• W4362596503 isParatext "false" @default.
• W4362596503 isRetracted "false" @default.
• W4362596503 workType "article" @default.